AccentCare is primed for further hospice growth, with both health system joint ventures and de novo activity as twin cornerstones of its strategy. Dallas-headquartered AccentCare provides hospice, home health, personal and palliative care across 32 states and in the District of Columbia. The company has an average annual census of more than 200,000 patients. AccentCare is a portfolio company of the private equity firm Advent International, which purchased the provider from Oak Hill Capital Partners in 2019 for an undisclosed sum. Hospice News sat down with AccentCare CEO Laura Tortorella to discuss the company’s priorities for 2025 and how it plans to execute on growth and an expanded continuum of care.
Read the full article: How AccentCare Pursues Growth via JVs, De Novos //
Source: https://hospicenews.com/2025/04/03/how-accentcare-pursues-growth-via-jvs-de-dovos